Switch theme
Sign up to access all valuation multiples
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
2018
1.6K+
LTM Revenue $577M
LTM EBITDA $66.8M
$471M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
The Cannabist Company has a last 12-month revenue (LTM) of $577M and a last 12-month EBITDA of $66.8M.
In the most recent fiscal year, The Cannabist Company achieved revenue of $331M and an EBITDA of $20.6M.
The Cannabist Company expects next 12-month revenue of XXX and NTM EBITDA of XXX
See The Cannabist Company valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $577M | XXX | $331M | XXX | XXX | XXX |
| Gross Profit | $223M | XXX | $121M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 37% | XXX | XXX | XXX |
| EBITDA | $66.8M | XXX | $20.6M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 6% | XXX | XXX | XXX |
| EBIT | -$25.3M | XXX | -$14.5M | XXX | XXX | XXX |
| EBIT Margin | -4% | XXX | -4% | XXX | XXX | XXX |
| Net Profit | -$207M | XXX | -$76.4M | XXX | XXX | XXX |
| Net Margin | -36% | XXX | -23% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $194M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, The Cannabist Company's stock price is CAD 0 (or $0).
The Cannabist Company has current market cap of CAD 36.0M (or $26.0M), and EV of CAD 653M (or $471M).
See The Cannabist Company trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $471M | $26.0M | XXX | XXX | XXX | XXX | $-0.32 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, The Cannabist Company has market cap of $26.0M and EV of $471M.
The Cannabist Company's trades at 1.4x EV/Revenue multiple, and 22.8x EV/EBITDA.
Equity research analysts estimate The Cannabist Company's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
The Cannabist Company has a P/E ratio of -0.2x.
See valuation multiples for The Cannabist Company and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $26.0M | XXX | $26.0M | XXX | XXX | XXX |
| EV (current) | $471M | XXX | $471M | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 9.8x | XXX | 22.8x | XXX | XXX | XXX |
| EV/EBIT | -25.8x | XXX | -32.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.2x | XXX | -0.3x | XXX | XXX | XXX |
| EV/FCF | -34.8x | XXX | -22.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialThe Cannabist Company's last 12 month revenue growth is -21%
The Cannabist Company's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
The Cannabist Company's rule of 40 is -31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
The Cannabist Company's rule of X is -40% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for The Cannabist Company and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -21% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | -15% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -31% | XXX | -14% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -40% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
The Cannabist Company acquired XXX companies to date.
Last acquisition by The Cannabist Company was XXXXXXXX, XXXXX XXXXX XXXXXX . The Cannabist Company acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was The Cannabist Company founded? | The Cannabist Company was founded in 2018. |
| Where is The Cannabist Company headquartered? | The Cannabist Company is headquartered in Canada. |
| How many employees does The Cannabist Company have? | As of today, The Cannabist Company has 1.6K+ employees. |
| Is The Cannabist Company publicy listed? | Yes, The Cannabist Company is a public company listed on NEOE. |
| What is the stock symbol of The Cannabist Company? | The Cannabist Company trades under CBST ticker. |
| When did The Cannabist Company go public? | The Cannabist Company went public in 2019. |
| Who are competitors of The Cannabist Company? | Similar companies to The Cannabist Company include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
| What is the current market cap of The Cannabist Company? | The Cannabist Company's current market cap is $26.0M |
| What is the current revenue of The Cannabist Company? | The Cannabist Company's last 12 months revenue is $577M. |
| What is the current revenue growth of The Cannabist Company? | The Cannabist Company revenue growth (NTM/LTM) is -21%. |
| What is the current EV/Revenue multiple of The Cannabist Company? | Current revenue multiple of The Cannabist Company is 1.1x. |
| Is The Cannabist Company profitable? | Yes, The Cannabist Company is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of The Cannabist Company? | The Cannabist Company's last 12 months EBITDA is $66.8M. |
| What is The Cannabist Company's EBITDA margin? | The Cannabist Company's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of The Cannabist Company? | Current EBITDA multiple of The Cannabist Company is 9.8x. |
| What is the current FCF of The Cannabist Company? | The Cannabist Company's last 12 months FCF is -$18.8M. |
| What is The Cannabist Company's FCF margin? | The Cannabist Company's last 12 months FCF margin is -3%. |
| What is the current EV/FCF multiple of The Cannabist Company? | Current FCF multiple of The Cannabist Company is -34.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
